Navigation Links
Eye Disease Rates High Among Latino Americans
Date:5/1/2010

As the population ages, more programs needed to address vision loss, experts say

SATURDAY, May 1 (HealthDay News) -- Latino Americans have higher rates of visual impairment, blindness, diabetic eye disease and cataracts than whites in the United States, researchers have found.

The analysis included data from more than 4,600 participants in the Los Angeles Latino Eye Study (LALES). Most of the study participants were of Mexican descent and aged 40 and older. In the four years after the participants enrolled in the study, the Latinos' rates of visual impairment and blindness were the highest of any ethnic group in the country, compared to other U.S. studies of different populations.

Nearly 3 percent of the study participants developed visual impairment and 0.3 percent developed blindness in both eyes. Among those aged 80 and older, 19.4 percent became visually impaired and 3.8 percent became blind in both eyes.

The study also found that 34 percent of participants with diabetes developed diabetic retinopathy (damage to the eye's retina), with the highest rate among those aged 40 to 59. The longer someone had diabetes, the more likely they were to develop diabetic retinopathy -- 42 percent of those with diabetes for more than 15 years developed the eye disease.

Participants who had visual impairment, blindness or diabetic retinopathy in one eye at the start of the study had high rates of developing the condition in the other eye, the study authors noted.

The researchers also found that Latinos were more likely to develop cataracts in the center of the eye lens than at the edge of the lens (10.2 percent versus 7.5 percent, respectively), with about half of those aged 70 and older developing cataracts in the center of the lens.

"This study showed that Latinos develop certain vision conditions at different rates than other ethnic groups. The burden of vision loss and eye disease on the Latino community is increasing as the population ages, and many eye diseases are becoming more common," Dr. Rohit Varma, principal investigator of LALES and director of the Ocular Epidemiology Center at the Doheny Eye Institute, University of Southern California, said in a news release from the U.S. National Eye Institute.

The findings are published in four reports in the May issue of the American Journal of Ophthalmology.

"These data have significant public health implications and present a challenge for eye care providers to develop programs to address the burden of eye disease in Latinos," Dr. Paul A. Sieving, director of the National Eye Institute, said in the news release.

The U.S. National Eye Institute provided funding for LALES.

More information

The U.S. Centers for Disease Control and Prevention has more about eye disorders.



-- Robert Preidt



SOURCE: U.S. National Eye Institute, news release, May 1, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Blood stem-cell transplant regimen reverses sickle cell disease in adults
2. New research identifies modifiable risk factors for heart disease
3. Distinct demographic profiles between Crohns disease and ulcerative colitis
4. Summit Medical Group hosts “Go Red Day” to Raise Awareness of Heart Disease and Stroke
5. Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs
6. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
7. Tests showing smokers their individual risk of future disease will help them quit, says paper
8. Researcher to track spread of disease, malware and power outages
9. Texas Health Dallas Launches Screening Program for Female Heart Disease
10. Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security
11. A better sign of blood vessel narrowing and early coronary artery disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... 2017 , ... The Topricin Companies, formerly Topical Biomedics, is ... natural, after-burn skin care product, Topricin After Burn Cream. , Overexposure ... conditions, including cancer. In the short term, overexposure to sun, wind and ...
(Date:7/24/2017)... Beach, California (PRWEB) , ... July 24, 2017 ... ... commercialization of autologous fat (adipose) transfer systems announces the issuance of United States ... ‘324 patent) for its adipose filtration technology. The '398 and '324 patents ...
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of the ... Health on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air about ... in China. , The article by Zidor Aldama described the situation in which Chinese ...
(Date:7/24/2017)... ... July 24, 2017 , ... A Southern California-based author has released a ... and how she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. ... she has risen above. , In “Memories,” readers get a firsthand look at what ...
(Date:7/24/2017)... Huntingdon Valley, PA (PRWEB) , ... July 24, 2017 , ... ... wind and rain storms wreak havoc across communities and often result in massive tree ... Top 3 actions homeowners can take now including tree trimming, tree cabling and hazardous ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... -- New York City-based market research firm Kalorama Information notes seven ... From new products to new costs, to the threat of ... study, Potential Pipeline Disruptors . Among them ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... the growing population and, to a more extreme extent, the ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
Breaking Medicine Technology: